All stock lists
Galectin Therapeutics Inc (GALT)
United States · Delayed Price · Currency is USD
Healthcare
3.19+0.00 (+0.06%)
Insider Score
––Not scored
GALT Insider Score
Insiders here have filed 2 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
GALT analyst forecast
Best analysts covering GALT
- HC Wainwright & Co.56%success rate · 9 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
GALT analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-06-23 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-12-17 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-08-14 |
| — | HC Wainwright & Co. | Neutral | — | — | Reiterated | 2025-04-02 |
| — | HC Wainwright & Co. | Neutral | — | — | Downgraded | 2024-12-27 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-11-15 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-08-16 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-04-09 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-04-01 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2023-08-15 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2023-05-17 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2023-03-03 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2022-05-17 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2021-04-16 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2020-08-13 |
| — | B. Riley FBR | Buy | — | — | Reiterated | 2020-04-03 |
| — | B. Riley Securities | Buy | — | — | Reiterated | 2020-04-03 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2020-03-17 |
| — | B. Riley FBR | Buy | — | — | Reiterated | 2019-02-13 |
| — | Roth Capital | Buy | — | — | Reiterated | 2017-10-19 |
| — | Seaport Global | Buy | — | — | Reiterated | 2017-10-06 |
| — | HC Wainwright & Co. | Buy | — | — | Upgraded | 2017-03-30 |
| — | H.C. Wainwright | Buy | — | — | Upgraded | 2017-03-30 |
| — | FBR Capital | Market Perform | — | — | Downgraded | 2016-10-03 |
| — | H.C. Wainwright | Neutral | — | — | Downgraded | 2016-09-29 |
| — | HC Wainwright & Co. | Neutral | — | — | Downgraded | 2016-09-29 |
| — | Roth Capital | Sell | — | — | Downgraded | 2016-09-28 |
| — | H.C. Wainwright | Buy | — | — | Reiterated | 2015-09-21 |
| — | Aegis Capital | Hold | — | — | Downgraded | 2014-08-01 |
| — | McNicoll Lewis Vlak | Buy | — | — | Reiterated | 2014-04-02 |
| — | Aegis Capital | Buy | — | — | Reiterated | 2014-02-12 |
| — | Ascendiant Capital | Buy | — | — | Reiterated | 2013-10-07 |
| — | Aegis Capital | Buy | — | — | Reiterated | 2012-07-25 |
| — | Dawson James | Buy | — | — | Reiterated | 2012-07-06 |
GALT earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-03-31 | -0.10 | -0.08 | $36.3M | $0 |
| 2026-05-15 | -0.06 | -0.08 | $0 | $0 |
| 2026-08-14 | -0.09 | -0.14 | $0 | $0 |
| 2026-11-13 | -0.05 | 0.00 | $0 | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.